NGC Update Service: September 2, 2013

September 2, 2013 New This Week Guideline Summaries American College of Radiology ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva. ACR Appropriateness Criteria® nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. This updates a previously published guideline summary. ACR Appropriateness Criteria® pediatric Hodgkin lymphoma. This updates a previously published guideline summary. ACR Appropriateness Criteria® treatment of stage I T1 glottic cancer. Cincinnati Children's Hospital Medical Center Best evidence statement (BESt). A formal follow-up process in the safety reporting system. Best evidence statement (BESt). Adding home based services to complement center based intervention for children with autism. Best evidence statement (BESt). Horticultural therapy for children and adolescents in residential treatment for mental health. Best evidence statement (BESt). Team building and mentoring for increased satisfaction and retention. Best evidence statement (BESt). Tracheal cuff pressure management. Best evidence statement (BESt). Vital sign monitoring in children and adolescents who are overweight or obese in the outpatient physical therapy clinic. Announcements How to Participate Submit guidelines: Visit our Submit Guidelines page for information on how to submit your organization's guidelines. Suggest a guideline for possible inclusion: Submit your suggestions for evidence-based guidelines that you would like to see included in NGC. Suggest a Guideline Synthesis topic: We welcome your suggestions for guideline synthesis topics! Revised Inclusion Criteria NGC has revised its Inclusion Criteria! Visit our updated Inclusion Criteria page to see the new criteria and send us your comments. Health Awareness Topics - September 2013 National Atrial Fibrillation Awareness Month (see related guidelines) National Sickle Cell Month (see related guidelines) National Traumatic Brain Injury Awareness Month (see related guidelines) Newborn Screening Awareness Month (see related guidelines) Ovarian Cancer Awareness Month (see related guidelines) Prostate Cancer Awareness Month (see related guidelines and guideline synthesis) World Alzheimer's Month (see related guidelines) Conference News The Guidelines International Network North America (G-I-N NA) continues to sponsor a monthly webinar series on topics of interest to the North American guideline community. Information on upcoming webinars, as well as audio files and slides from past webinars, is available on the G-I-N Web site. U.S. Food and Drug Administration (FDA) Advisory August 29, 2013: Gilenya (fingolimod): FDA is alerting the public that a patient in Europe diagnosed with possible multiple sclerosis (MS) has developed a rare and serious brain infection after taking the drug Gilenya (fingolimod). Patients should not stop taking Gilenya without first discussing any questions or concerns with their health care professionals. FDA is providing this alert while continuing to investigate the PML case, and is working with Gilenya's manufacturer, Novartis, to obtain and review all available information about this occurrence. FDA will communicate its final conclusions and recommendations after the evaluation is complete. NGC's Sister Resources Find Innovations and QualityTools classified by disease or clinical category, patient population, setting of care, stage of care, and more in AHRQ's Health Care Innovations Exchange Web site. Look for Quality Measures in AHRQ's National Quality Measures Clearinghouse (NQMC).    How satisfied are you with this e-mail bulletin? Give Us Your Feedback Subscriber Services: Change Your Profile | Unsubscribe | Help Stay Connected: Contact Us | Social Media This email was sent to buzzhairs@gmail.com using GovDelivery, on behalf of: Agency for Healthcare Research and Quality (AHRQ) · 540 Gaither Road · Rockville, MD 20850 · 301-427-1364